QP-Brain®
Overview
QP-Brain® is an AI-powered medical imaging processing application developed by Quibim S.L. designed to enhance magnetic resonance imaging (MRI) analysis of the brain, particularly in the context of an aging population and the increasing prevalence of neurodegenerative diseases.
The software provides quantitative analysis of patients’ brain MRI scans, delivering automatic quantification and display of imaging findings and data. It precisely measures absolute and relative volumes of grey and white matter, cerebrospinal fluid, and analyzes 132 distinct brain regions (left/right). QP-Brain® also identifies and quantifies White Matter Hyperintensities (WMH) load and location, utilizing 2D FLAIR input.
By comparing this quantitative data with an extensive normative database, the tool aids in detecting subtle alterations and early changes in brain atrophy and lesions, which is crucial for the diagnosis and monitoring of conditions such as Alzheimer’s disease, multiple sclerosis, and various forms of dementia. It streamlines and improves the efficiency of radiological reporting by providing objective and quantitative data, thereby reducing the potential for human error and optimizing the process of radiological reporting.
QP-Brain® integrates seamlessly into existing clinical workflows, automatically receiving brain images from Picture Archiving and Communication Systems (PACS) and delivering structured, quantitative reports directly back to PACS environments, appearing as an additional series in a patient folder. This eliminates the need for additional workstations or viewing environments.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Quantitative analysis of brain MRI
- Automatic quantification and display of imaging findings
- Measures absolute and relative volumes of grey and white matter, and cerebrospinal fluid
- Analyzes 132 distinct brain regions (L/R)
- White Matter Hyperintensities (WMH) load and location analysis
- Early atrophy and lesion detection
- Objective longitudinal reporting and disease tracking
- Seamless integration with PACS for automated workflow
- Structured and quantitative radiology report generation
- Leverages an extensive normative database for comparison
Use Cases
- Early diagnosis of neurodegenerative diseases (e.g., Alzheimer's, Multiple Sclerosis, Dementia)
- Monitoring disease progression and treatment effectiveness
- Optimizing and standardizing radiological reporting
- Quantitative assessment for central nervous system disorders
- Supporting clinical research in neurology
What Physicians Need to Know
QP-Brain® can significantly enhance the interpretation and visualization of brain imaging data, especially for neurodegenerative diseases. It provides objective quantitative results that can confirm visual findings and offers longitudinal reporting to track disease evolution over time. The automated analysis of brain structure volumes and white matter hyperintensities can aid in early diagnosis and treatment strategies. The generated quantitative reports can be integrated into existing radiological reporting workflows, improving efficiency and standardization.
QP-Brain® is designed for seamless integration into the workflow of radiologists and neurologists. Its outputs are available for viewing in standard hospital PACS (Picture Archiving and Communication System) environments, appearing as an additional series in a patient folder, eliminating the need for additional workstations or viewing environments. The tool generates a quantitative report that can be sent directly to PACS.
Details
| Category | Neurology AI, Radiology & Imaging AI |
| Pricing | Contact vendor |
| Deployment | Cloud-based with secure cloud architecture; can be installed on hospital servers behind firewalls. |
| Compliance | |
| BAA Available | Yes AI-estimated |
| HIPAA Compliant | Yes AI-estimated |
| FDA Status | Cleared AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Neurology, Radiology |
What the Web Says
QP-Brain® is an AI-based software developed by Quibim for the early-stage quantification of neurological diseases. It analyzes brain MRI scans to detect and quantify early brain atrophy and lesions, providing objective data for diagnosis and monitoring of conditions like Alzheimer's, multiple sclerosis, and dementia. The software aims to enhance the efficiency of radiological reporting and improve diagnostic accuracy by offering quantitative evaluations that complement traditional qualitative analysis. QP-Brain® has received regulatory clearances in the US (FDA 510(k)), EU (CE mark), and UK (UKCA mark), making it available for clinical use in these regions.
Overall: PositiveStrengths
- Accelerates brain diagnosis with AI-based quantification of early brain atrophy and lesions.
- Provides precise, quantitative information and automates tasks, enhancing workflows and improving diagnostic accuracy.
- Offers detailed characterization of white matter hyperintensities (WMH) and brain volumetry.
- Integrates seamlessly with existing PACS systems, making outputs available in standard hospital environments without additional workstations.
- Aids in identifying patterns of brain atrophy and neurodegenerative diseases at earlier stages.
- Compliant with GDPR and HIPAA for secure processing and analysis of patient data.
Limitations
No significant limitations found in public reviews. Consider checking vendor documentation or requesting a demo for a thorough evaluation.
Based on reviews from: healthcaretechoutlook.com, recall.it, ncdhhs.gov, elifesciences.org, quibim.ai, g2.com, qynapse.com, thesiliconreview.com, healthairegister.com, microsoft.com, reddit.com, koreamed.org, mriquestions.com, bioworld.com, youtube.com, utsouthwestern.edu, nih.gov
Last updated: 2026-10-31
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate QP-Brain®
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for QP-Brain®.
Quibim | QP-Brainu00ae
Quibim
Frequently Asked Questions
Investors who backed QP-Brain®
Funded through the company that built this tool.
